Cargando…

Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay

Background: Lipoprotein particles with abnormal compositions, such as lipoprotein X (LP-X) and lipoprotein Z (LP-Z), have been described in cases of obstructive jaundice and cholestasis. The study objectives were to: (1) develop an NMR-based assay for quantification of plasma/serum LP-Z particles, (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bedi, Shimpi, Garcia, Erwin, Jeyarajah, Elias J., Shalaurova, Irina, Perez-Matos, Maria Camila, Jiang, Z. Gordon, Dullaart, Robin P. F., Matyus, Steven P., Kirk, William J., Otvos, James D., Davidson, W. Sean, Connelly, Margery A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564541/ https://www.ncbi.nlm.nih.gov/pubmed/32927635 http://dx.doi.org/10.3390/jcm9092915

Ejemplares similares

Ketone Bodies Are Mildly Elevated in Subjects with Type 2 Diabetes Mellitus and Are Inversely Associated with Insulin Resistance as Measured by the Lipoprotein Insulin Resistance Index
por: Garcia, Erwin, et al.
Publicado: (2020)

High-throughput nuclear magnetic resonance measurement of citrate in serum and plasma in the clinical laboratory
por: Garcia, Erwin, et al.
Publicado: (2021)

A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort
por: Flores-Guerrero, Jose L., et al.
Publicado: (2020)

Nuclear Magnetic Resonance-Measured Ionized Magnesium Is Inversely Associated with Type 2 Diabetes in the Insulin Resistance Atherosclerosis Study
por: Garcia, Erwin, et al.
Publicado: (2022)

Profoundly Disturbed Lipoproteins in Cirrhotic Patients: Role of Lipoprotein-Z, a Hepatotoxic LDL-like Lipoprotein
por: van den Berg, Eline H., et al.
Publicado: (2022)

The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B
por: Garcia, Erwin, et al.
Publicado: (2020)

High Betaine, a Trimethylamine N-Oxide Related Metabolite, Is Prospectively Associated with Low Future Risk of Type 2 Diabetes Mellitus in the PREVEND Study
por: Garcia, Erwin, et al.
Publicado: (2019)

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2017)

Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects
por: Dullaart, R. P. F., et al.
Publicado: (2016)

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
por: Connelly, Margery A., et al.
Publicado: (2017)

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children
por: Connelly, Margery A., et al.
Publicado: (2016)

Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol‐associated hepatitis
por: Hu, Kunpeng, et al.
Publicado: (2021)

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
por: Orchard, Trevor J., et al.
Publicado: (2017)

Association of beta‐hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2020)

Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study
por: Sokooti, Sara, et al.
Publicado: (2021)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Vantera Mediated Quantification of Urine Citrate and Creatinine: A New Technology to Assess Risk of Nephrolithiasis
por: Matyus, Steven P., et al.
Publicado: (2022)

Lipoprotein insulin resistance score and branched-chain amino acids increase after adrenalectomy for unilateral aldosterone-producing adenoma: a preliminary study
por: Adolf, Christian, et al.
Publicado: (2020)

Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study
por: Schutten, Joëlle C., et al.
Publicado: (2019)

Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity: A Pooled Cohort Analysis
por: Singh, Kavisha, et al.
Publicado: (2020)

Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study
por: Sokooti, Sara, et al.
Publicado: (2021)

Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver Failure
por: Waksman, Ori, et al.
Publicado: (2022)

GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2015)

Evaluation of lipoprotein (a) [Lp(a)] and lipid abnormalities in patients with newly detected hypertension and its association with severity of hypertension
por: Mahto, Subodh Kumar, et al.
Publicado: (2022)

Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification
por: Pechlivanis, Sonali, et al.
Publicado: (2020)

Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk
por: García-Gavilán, Jesús F., et al.
Publicado: (2022)

A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2018)

Correction: Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk
por: Garcia‑Gavilan, Jesus F., et al.
Publicado: (2022)

Detection of Lipoprotein X (LpX): A challenge in patients with severe hypercholesterolaemia
por: Ćwiklińska, Agnieszka, et al.
Publicado: (2020)

Higher Free Triiodothyronine Is Associated With Higher HDL Particle Concentration and Smaller HDL Particle Size
por: Post, Adrian, et al.
Publicado: (2022)

High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
por: Sokooti, Sara, et al.
Publicado: (2020)

High Plasma Branched-Chain Amino Acids Are Associated with Higher Risk of Post-Transplant Diabetes Mellitus in Renal Transplant Recipients
por: Osté, Maryse C. J., et al.
Publicado: (2020)

Relationship Between Lipoprotein (a) [Lp(a)] and Cognition in Different Ischemic Stroke Subtypes
por: Li, Jingjing, et al.
Publicado: (2021)

Mahalanobis distance, a novel statistical proxy of homeostasis loss is longitudinally associated with risk of type 2 diabetes
por: Flores-Guerrero, Jose L., et al.
Publicado: (2021)

Effects of Amount, Intensity, and Mode of Exercise Training on Insulin Resistance and Type 2 Diabetes Risk in the STRRIDE Randomized Trials
por: Ross, Leanna M., et al.
Publicado: (2021)

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19
por: Ballout, Rami A., et al.
Publicado: (2021)

Plasma Levels of Retinol Binding Protein 4 Relate to Large VLDL and Small LDL Particles in Subjects with and without Type 2 Diabetes
por: Wessel, Hanna, et al.
Publicado: (2019)

Plasma Branched-Chain Amino Acids and Risk of Incident Type 2 Diabetes: Results from the PREVEND Prospective Cohort Study
por: Flores-Guerrero, Jose L., et al.
Publicado: (2018)

Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
por: Almesned, Mohammad A., et al.
Publicado: (2021)

Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial
por: Eppinga, Ruben N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b9ictaq60um6l9f9j2s8fts40d